Evidence map›Paper›PMID 14654698›Full record

ArticleNucleic acids research2003

Repair of a minimal DNA double-strand break by NHEJ requires DNA-PKcs and is controlled by the ATM/ATR checkpoint.

Christian Kühne, Marie-Louise Tjörnhammar, Sándor Pongor, Lawrence Banks, András Simoncsits

Open access · bronzeAbstract read
In one paragraph

Article in Nucleic acids research, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Antiviral strategies targeting herpesviruses.Journal of virus eradication · 2021
    Review
  5. Review
  6. Article
  7. ATM-dependent pathways of chromatin remodelling and oxidative DNA damage responses.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2017
    Review
  8. Article
  9. Inhibiting DNA-PKBiochemical and biophysical research communications · 2017
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Christian KühneInternational Center for Genetic Engineering and Biotechnology (ICGEB), Area Science Park, Padriciano 99, I-34000 Trieste, Italy. kuehne@icgeb.org
Marie-Louise Tjörnhammar
Sándor Pongor
Lawrence Banks
András Simoncsits
International Centre for Genetic Engineering and Biotechnology · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mammalian cells primarily rejoin DNA double-strand breaks (DSBs) by the non-homologous end-joining (NHEJ) pathway. The joining of the broken DNA ends appears directly without template and accuracy is ensured by the NHEJ factors that are under ATM/ATR regulated checkpoint control. In the current study we report the engineering of a mono-specific DNA damaging agent. This was used to study the molecular requirements for the repair of the least complex DSB in vivo. Single-chain PvuII restriction enzymes fused to protein delivery sequences transduce cells efficiently and induce blunt end DSBs in vivo. We demonstrate that beside XRCC4/LigaseIV and KU, the DNA-PK catalytic subunit (DNA-PKcs) is also essential for the joining of this low complex DSB in vivo. The appearance of blunt end 3'-hydroxyl and 5'-phosphate DNA DSBs induces a significantly higher frequency of anaphase bridges in cells that do not contain functional DNA-PKcs, suggesting an absolute requirement for DNA-PKcs in the control of chromosomal stability during end joining. Moreover, these minimal blunt end DSBs are sufficient to induce a p53 and ATM/ATR checkpoint function.

Indexed as

Cell CycleDNA DamageDNA HelicasesDNA RepairAnimalsAntigens, NuclearAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell LineDeoxyribonucleases, Type II Site-SpecificDNADNA-Activated Protein KinaseDNA-Binding ProteinsGene DeletionGene Products, tatHydrolysisAntigens, NuclearAtaxia Telangiectasia Mutated ProteinsATM protein, humanCAGCTG-specific type II deoxyribonucleasesCell Cycle ProteinsDeoxyribonucleases, Type II Site-SpecificDNADNA-Activated Protein KinaseDNA-Binding ProteinsDNA HelicasesGene Products, tatKu AutoantigenProtein Serine-Threonine KinasesTumor Suppressor Protein p53Tumor Suppressor ProteinsXRCC4 protein, humanXRCC5 protein, humanXrcc6 protein, human

Identifiers

PMID14654698
PMCPMC291875
OpenAlexW1965511479

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.